Search results for: psoriatic arthritis

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | November 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

Gretchen Henkel | September 1, 2013

Visionary rheumatologist credited with developing new spondylarthritis criteria, collaborating on the OASIS study, and promoting the 3E Initiative in rheumatology

Rheumatologists on the Move

Amanda Rillo | September 1, 2013

Awards, appointments, and announcements in the world of rheumatology

How Rheumatologists Can Connect with Congress during August Recess

Staff | July 1, 2013

Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices

ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy

Kimberly Retzlaff | May 1, 2013

Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | May 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Tech Talk: Contraption Reduces Pain of Rheumatic Therapy Injections

Thomas R. Collins | May 1, 2013

Innovative device called Buzzy applies high-frequency vibration sensation and cold to soothe sting of shots

Susceptibility Loci Shed Light on Fundamental Pathways of Psoriasis

Lara C. Pullen, PhD | April 26, 2013

Investigators have described 15 new psoriasis susceptibility loci. The loci highlight the importance of the skin in both acquired and innate host defense and identify the innate immune response as a key factor in psoriasis.

CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions

Gretchen Henkel | December 1, 2012

The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit

Ethical Concerns Influence What Constitutes Clear and Full Disclosure for Physicians

Bernard Rubin, DO, MPH | December 1, 2012

Money received from industry by physicians who can influence medical practice by their research, opinions, or roles in decision-making bodies should be clearly and fully disclosed